We are pleased to share that ITN Business has created a video about the Medicines Patent Pool for World AIDS Day. The video highlights how MPP’s voluntary licensing model has supported access to essential medicines in the HIV field. With over 1 billion packs of dolutegravir-based treatments now supplied to 128 countries, MPP-licensed products have reached 24 million people. 

 The video takes us to Kenyatta National Hospital in Kenya, where we see firsthand how HIV treatment has become more accessible and is transforming lives. We meet Josephine, a mother of two who has lived with HIV for over two decades and hear her story about the impact of affordable treatment. Nelson Otwoma, Director of NEPHAK, explains how the availability of generic dolutegravir through public health-oriented voluntary licensing and the work of many partners has been a game changer for Kenya, making treatment affordable and accessible to millions. 

 The film also explores the potential of the MPP model to support access to other essential medicines, especially in cancer treatment. We hear from Kennedy Odhiambo, a Nairobi resident receiving oesophageal cancer treatment, who shares the challenges of accessing affordable cancer medication.

This film is part of the ITN Business programme “HIV: Towards Zero by 2030”, hosted by Sharon Thomas. We invite you to watch and learn more about the impact of MPP’s work and the ongoing efforts to improve access to life-saving medicines. 

Access MPP’s report demonstrating how voluntary licensing can be good for health and smart for business: https://medicinespatentpool.org/news-publications-post/voluntary-licensing-right-for-health-smart-for-business-report